Active	Status	Sponsor type	Region	Phase	Filter
5 Active 5 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Maleux, Geert
NCT01514617: Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization	Active, not recruiting	N/A	100	Europe	Diffusion -and perfusion weighted MRI including iv contrast agent injection, Dotarem	Universitaire Ziekenhuizen KU Leuven	Leiomyomas	12/25	12/25
NCT05716568: Patient Tailored Contrast Volume for Preoperative CT Angiography of the Aorta	Completed	N/A	60	NA	Contrast dose reduction, CT-angiography	Universitaire Ziekenhuizen KU Leuven	Aortic Aneurysm	12/15	12/15
NCT05013970: Transcatheter Arterial Embolization in Patients With Mild to Moderate Osteoarthritis	Withdrawn	N/A	15	NA	Clinical assessment, Radiographic imaging	Universitaire Ziekenhuizen KU Leuven	Osteoarthritis, Knee	12/22	12/22
HoLiBreast, NCT06142344: Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients	Recruiting	N/A	13	Europe	Quiremspheres™, Radioembolization with Quiremspheres™	The Netherlands Cancer Institute, Universitaire Ziekenhuizen KU Leuven	Liver Metastases, Breast Cancer	10/25	01/26
BIOPEARL-ONE, NCT05911633: BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)	Suspended	N/A	50	Europe	BioPearl™	Terumo Europe N.V.	Hepatocellular Carcinoma Non-resectable	06/26	11/27